One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Editor's Picks December 2020
doi : 10.1111/jdv.17031
Volume34, Issue12 December 2020 Pages 2683-2683
COVID?19 has changed our society as well as Dermatology
J. Ring
doi : 10.1111/jdv.17033
Volume34, Issue12 December 2020 Pages 2684-2684
Parkinson’s disease and skin cancer in Korean patients
J.C. Cardoso
doi : 10.1111/jdv.16984
Volume34, Issue12 December 2020 Pages 2685-2686
The relationship between Parkinson’s disease (PD) and cancer has long been a subject of study. Interestingly, patients with PD have a lower relative risk of almost all types of cancer compared with their age?matched general population, but the reverse occurs with skin cancer, particularly melanoma.
Post acne scars treatment ? do picosecond lasers offer a superior non?ablative modality?
M. Lepidoth A. Levi
doi : 10.1111/jdv.17017
Volume34, Issue12 December 2020 Pages 2687-2688
Linked article: H.H. Kwon et al. J Eur Acad Dermatol Venereol 2020; 34: 2907–2913. https://doi.org/10.1111/jdv.16643.
Psychotrauma and the skin
C. Szab?
doi : 10.1111/jdv.17030
Volume34, Issue12 December 2020 Pages 2689-2690
Linked article: S. Gielen et al. J Eur Acad Dermatol Venereol 2020; 34: 2877–2883. https://doi.org/10.1111/jdv.16828
Pioneers in Dermatology and Venereology: an interview with Prof. Anders Vahlquist
A. Vahlquist
doi : 10.1111/jdv.17032
Volume34, Issue12 December 2020 Pages 2691-2692
No abstract is available for this article.
European dermatology forum – updated guidelines on the use of extracorporeal photopheresis 2020 – part 1
R. Knobler P. Arenberger A. Arun C. Assaf M. Bagot G. Berlin A. Bohbot P. Calzavara?Pinton F. Child A. Cho L.E. French A.R. Gennery R. Gniadecki H.P.M. Gollnick E. Guenova P. Jaksch C. Jantschitsch C. Klemke J. Ludvigsson E. Papadavid J. Scarisbrick T. Schwarz R. Stadler P. Wolf J. Zic C. Zouboulis A. Zuckermann H. Greinix
doi : 10.1111/jdv.16890
Volume34, Issue12 December 2020 Pages 2693-2716
Following the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T?cell lymphoma published in 1983, this technology has received continued use and further recognition for additional earlier as well as refractory forms.
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
A. Wollenberg S. Christen?Z?ch A. Taieb C. Paul J.P. Thyssen M. de Bruin?Weller C. Vestergaard J. Seneschal T. Werfel M.J. Cork B. Kunz R. F?lster?Holst M. Trzeciak U. Darsow Z. Szalai M. Deleuran L. von Kobyletzki S. Barbarot A. Heratizadeh U. Gieler D.J. Hijnen S. Weidinger L. De Raeve ?. Svensson D. Simon J.F. Stalder J. Ring for the European Task Force on Atopic Dermatitis/EADV Eczema Task Force
doi : 10.1111/jdv.16892
Volume34, Issue12 December 2020 Pages 2717-2744
Atopic dermatitis (AD) is a highly pruritic, chronic inflammatory skin disease. The diagnosis is made using evaluated clinical criteria. Disease activity and burden are best measured with a composite score, assessing both objective and subjective symptoms, such as SCORing Atopic Dermatitis (SCORAD).
Osteoporosis and bone health in autoimmune blistering skin disease—an evidenced based review
M. Kang A. Bilgic M. Radjenovic D.F. Murrell
doi : 10.1111/jdv.16334
Volume34, Issue12 December 2020 Pages 2745-2756
Autoimmune blistering skin diseases (AIBD) encompass a group of diseases characterised by cutaneous and/or mucocutaneous fragility. Multiple risk factors contributing to osteoporosis exist in AIBD patients, including use of long?term systemic corticosteroid therapy (SCT), decreased mobility and the presence of chronic inflammation.
Emerging role of dermal compartment in skin pigmentation: comprehensive review
R. Kapoor S.K. Dhatwalia R. Kumar S. Rani D. Parsad
doi : 10.1111/jdv.16404
Volume34, Issue12December 2020Pages 2757-2765
The variations in human skin colour mainly occur due to differences in the distribution of melanin pigment throughout the body, synthesized by epidermal melanocytes which are further taken up by keratinocytes present in epidermis. Recently, it has been discovered that besides these cells, dermis derived fibroblast factors also play a prominent role in regulating skin pigmentation.
Gastrointestinal involvement of primary skin diseases
C.?Y. Lu M.?S. Hsieh K.?C. Wei M. Ezmerli C.?H. Kuo W. Chen
doi : 10.1111/jdv.16676
Volume34, Issue12December 2020Pages 2766-2774
Less is known about gastrointestinal (GI) involvement of primary skin diseases due to the difference in embryology, histology, microbiology and physiology between integument and alimentary tract.
Parkinson’s disease and skin cancer risk: a nationwide population?based cohort study in Korea
H.J. Ryu J.?H. Park M. Choi J.?H. Jung K. Han D.?Y. Kwon D.?H. Kim Y.?G. Park
doi : 10.1111/jdv.16462
Volume34, Issue12December 2020Pages 2775-2780
Previous studies have reported that patients with Parkinson’s disease (PD) have a significantly lower risk of cancer. Studies reporting prevalence of skin cancers in Parkinson’s disease mostly involve Caucasians.
Hexyl aminolevulinate, 5?aminolevulinic acid nanoemulsion and methyl aminolevulinate in photodynamic therapy of non?aggressive basal cell carcinomas: A non?sponsored, randomized, prospective and double?blinded trial
M. Salmivuori M. Gr?nroos T. Tani I. P?l?nen J. R?s?nen L. Annala E. Snellman N. Neittaanm?ki
doi : 10.1111/jdv.16357
Volume34, Issue12December 2020Pages 2781-2788
In the photodynamic therapy (PDT) of non?aggressive basal cell carcinomas (BCCs), 5?aminolevulinic acid nanoemulsion (BF?200ALA) has shown non?inferior efficacy when compared with methyl aminolevulinate (MAL), a widely used photosensitizer. Hexyl aminolevulinate (HAL) is an interesting alternative photosensitizer. To our knowledge, this is the first study using HAL?PDT in the treatment of BCCs.
Efficacy and safety of panitumumab alone or in association with radiotherapy in unresectable cutaneous squamous cell carcinoma
K. Hourbeigt M. Ehret L. Visseaux A. Durlach A. Petit J. Sanchez A. Grange?Prunier C. Barbe S. Servagi?Vernat F. Grange
doi : 10.1111/jdv.16465
Volume34, Issue12December 2020Pages 2789-2794
The prognosis of unresectable cutaneous squamous cell carcinomas is very poor.
Correlation between the hemoporfin?mediated photodynamic treatment response and the dermoscopy vascular pattern in patients with a port?wine stain: a prospective study
X. Wang H. Suo Y. Gao H. Du Y. Fu S. Sha Y. Liu X. Su X. An X. Guo Y. Li J. Tao
doi : 10.1111/jdv.16596
Volume34, Issue12December 2020Pages 2795-2801
Vascular targeted photodynamic therapy (PDT) is a novel and promising therapy for the treatment of port?wine stains (PWS). There has been little prior exploration to our knowledge of how the dermatological vascular pattern may predict the response to PDT.
The presence of eccentric hyperpigmentation should raise the suspicion of melanoma
S. Borsari F. Peccerillo R. Pampena M. Lai M. Spadafora E. Moscarella A. Lallas M.A. Pizzichetta I. Zalaudek L. Del Regno K. Peris G Pellacani C. Longo
doi : 10.1111/jdv.16604
Volume34, Issue12December 2020Pages 2802-2808
Melanocytic lesions with eccentric hyperpigmentation (EH), even though without other dermatoscopic features of melanoma, are often excised.
Tofacitinib in psoriatic arthritis patients: skin signs and symptoms and health?related quality of life from two randomized phase 3 studies
J.F. Merola K.A. Papp P. Nash J. Gratac?s W.H. Boehncke D. Thaçi D. Graham M?A. Hsu C. Wang J. Wu P. Young
doi : 10.1111/jdv.16433
Volume34, Issue12December 2020Pages 2809-2820
Psoriatic arthritis (PsA) is a chronic, systemic immune?mediated inflammatory musculoskeletal disease. The onset of dermatologic symptoms often precedes rheumatic manifestations. Tofacitinib is an oral Janus kinase inhibitor for the treatment of PsA that has been shown to improve dermatologic symptoms in patients with PsA.
Real?world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group
E. del Alc?zar J.A. Su?rez?Pérez S. Armesto R. Rivera E. Herrera?Acosta P. Herranz I. Mart?n E. Montesinos M. Hospital E. Vilarrasa M. Ferran R. Ruiz?Villaverde A. Sahuquillo?Torralba D.P. Ruiz?Genao S. Pérez?Barrio C. Mu?oz M. Llamas F. Valent? M.J. Mitxelena A. L?pez?Ferrer G. Carretero D. Vidal J. Mollet I. Belinch?n J.M. Carrascosa
doi : 10.1111/jdv.16439
Volume34, Issue12December 2020Pages 2821-2829
Little has been published on the real?world effectiveness and safety of apremilast in psoriasis.
Efficacy of risankizumab in patients with moderate?to?severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy: an integrated analysis of the phase III UltIMMa?1 and UltIMMa?2 studies
B. Strober A. Menter C. Leonardi K. Gordon J. Lambert L. Puig H. Photowala M. Longcore T. Zhan P. Foley
doi : 10.1111/jdv.16521
Volume34, Issue12December 2020Pages 2830-2838
Risankizumab is a humanized IgG monoclonal antibody that selectively inhibits interleukin?23 through binding the p19 subunit. In Phase 3 trials, risankizumab demonstrated superior efficacy compared with adalimumab and ustekinumab in patients with moderate?to?severe plaque psoriasis. Here, we evaluated the impact of baseline characteristics on efficacy of risankizumab compared with ustekinumab in patients with moderate?to?severe plaque psoriasis.
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real?world multicentre Italian study
A. Dattola A. Balato M. Megna P. Gisondi G. Girolomoni C. De Simone G. Caldarola E. Cama S. Piaserico M.C. Fargnoli R. Fidanza A. Parodi M. Burlando A. Offidani F. Diotallevi C. Potenza A. Conti A. Chiricozzi E. Campione L. Bianchi
doi : 10.1111/jdv.16606
Volume34, Issue12December 2020Pages 2839-2845
Certolizumab, a pegylated tumour necrosis factor?? inhibitor, reduced disease activity in randomized trials of patients with psoriasis and psoriatic arthritis. Real?life data are missing.
Perception and determinants of stigmatization of people with psoriasis in the German population
R. Sommer J. Topp U. Mrowietz N. Zander M. Augustin
doi : 10.1111/jdv.16436
Volume34, Issue12December 2020Pages 2846-2855
Perception of psoriasis in the general population is characterized by knowledge deficits and prejudice against those affected. The extent and possible predictors of stigmatizing attitudes remain unclear.
Hand strength and dexterity in individuals with hand eczema
H.M. Passlov A. Pontén J. Bj?rk B. Rosén M. Bruze C. Svedman M. Isaksson
doi : 10.1111/jdv.16401
Volume34, Issue12December 2020Pages 2856-2862
Patients with hand eczema often describe symptoms such as pain, clumsiness and difficulty flexing their fingers, thus impairing the function of the hand.
Characterization of CD19+CD24hiCD38hi B cells in Chinese adult patients with atopic dermatitis
Y. Gu K. Li J. Sun J. Zhang
doi : 10.1111/jdv.16399
Volume34, Issue12December 2020Pages 2863-2870
Atopic dermatitis (AD) is a chronic inflammatory skin disease. Human interleukin?10+B cells (B10 cells) is one of regulatory B cells and is enriched in CD19+CD24hiCD38hi B cells. A little is known about these cells in atopic dermatitis.
Protocol for the development of a core domain set for hand eczema trials
H. R?nsch C. Apfelbacher R. Brans R. Ofenloch M.L.A. Schuttelaar E. Weisshaar A. Bauer
doi : 10.1111/jdv.16429
Volume34, Issue12December 2020Pages 2871-2876
Clinical hand eczema trials measure a variety of outcome domains to determine the success of interventions. This considerably limits the comparability and overall confidence in the study results, and thereby the strength of recommendations for clinical practice.
Hidradenitis suppurativa is associated with childhood and lifetime traumatic events: a case–control study
S. Gielen S.R. Janmohamed A. Van Laethem V. Del Marmol M. Suppa J. Gutermuth R. Willemsen
doi : 10.1111/jdv.16828
Volume34, Issue12December 2020Pages 2877-2883
Negative life events in childhood can increase the susceptibility to autoimmune and inflammatory diseases. Hidradenitis suppurativa (HS) is a systemic inflammatory disease affecting the apocrine sweat glands, characterized by abscesses, fistulas and inflammatory nodules. It is unknown whether adult HS is associated with traumatic events.
Long?term outcomes of rituximab therapy in pemphigus
I. Shimanovich T. Baumann E. Schmidt D. Zillikens C.M. Hammers
doi : 10.1111/jdv.16561
Volume34, Issue12December 2020Pages 2884-2889
Rituximab induces a rapid remission in most patients with pemphigus.
Increased expression of in situ IL?31RA and circulating CXCL8 and CCL2 in pemphigus herpetiformis suggests participation of the IL?31 family in the pathogenesis of the disease
K.L. Morais D. Miyamoto R.L. Orfali C.W. Maruta C.G. Santi M.N. Sotto L.F.F. da Silva A.C.C.C Branco M.N. Sato V. Aoki
doi : 10.1111/jdv.16730
Volume34, Issue12December 2020Pages 2890-2897
Pemphigus herpetiformis (PH) is a rare clinical subtype of pemphigus with the presence of urticarial plaques, severe pruritus, rare acantholysis and eosinophilic spongiosis.
Comorbidities in pediatric alopecia areata
R.Z. Conic N.L. Tamashunas G. Damiani G. Fabbrocini M. Cantelli Young Dermatologists Italian Network W.F. Bergfeld
doi : 10.1111/jdv.16727
Volume34, Issue12December 2020Pages 2898-2901
Comorbidities are associated with higher health care costs, complex management, and poorer health outcomes. Identification and treatment of comorbid conditions in paediatric alopecia areata (AA) patients could provide an opportunity to improve health outcomes.
Differences in human papilloma virus vaccination prevalence, testing, knowledge on vaccination, cancer awareness and sexual activities between male and female medical and non?medical students
P.V. Chernyshov T. Semushyna
doi : 10.1111/jdv.16845
Volume34, Issue12December 2020Pages 2902-2906
Although most European countries experienced a decrease in cervical cancer mortality, Ukraine, Latvia and Belarus have experienced an increase in mortality. There is no national vaccination programme against human papilloma virus (HPV) in Ukraine, and vaccination rates are low.
Comparison of a 1064?nm neodymium?doped yttrium aluminum garnet picosecond laser using a diffractive optical element vs. a nonablative 1550?nm erbium?glass laser for the treatment of facial acne scarring in Asian patients: a 17?week prospective, randomized, split?face, controlled trial
H.H. Kwon S.H. Yang Y.J. Cho E. Shin M. Choi Y. Bae J.Y. Jung G.?H. Park
doi : 10.1111/jdv.16643
Volume34, Issue12December 2020Pages 2907-2913
Novel picosecond lasers using a diffractive optical element (P?DOE) have been available for skin resurfacing with distinct mechanisms. However, there are limited data directly comparing P?DOE and conventional fractional lasers for the treatment of atrophic acne scarring.
Invivo characterization of healthy human skin with a novel, non?invasive imaging technique: line?field confocal optical coherence tomography
J. Monnier L. Tognetti M. Miyamoto M. Suppa E. Cinotti M. Fontaine J. Perez C. Orte Cano O. Yélamos S. Puig A. Dubois P. Rubegni V. del Marmol J. Malvehy J.L. Perrot
doi : 10.1111/jdv.16857
Volume34, Issue12December 2020Pages 2914-2921
Line?field confocal optical coherence tomography (LC?OCT) is a non?invasive optical technique recently developed for skin examination in vivo. It provides real?time, high?resolution vertical images with an isotropic resolution of ~1 µm and a penetration depth of ~500 µm.
Corrigendum: Management of primary cutaneous lymphoma patients during COVID?19 pandemic: EORTC CLTF guidelines
E. Papadavid J. Scaribrick P. Ortiz Romero P. Quaglino M. Vermeer R. Knobler R. Stadler M. Bagot
doi : 10.1111/jdv.16897
Volume34, Issue12December 2020Pages 2922-2922
A Special Thank You to Our Reviewers!
doi : 10.1111/jdv.17034
Volume34, Issue12December 2020Pages 2923-2924
Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients
A. Reymundo A. Fern?ldez?Bern?ldez A. Reolid B. Butr?n P. Fern?ndez?Rico P. Mu?oz?Hern?ndez D. De Argila Thomas Wiesner M. Llamas?Velasco
doi : 10.1111/jdv.16707
Volume34, Issue12December 2020Pages e755-e757
COVID?19 and outbreak of chilblains: are they related?
C. Lesort J. Kanitakis A. Villani E. Ducroux P. Bouschon K. Fattouh B. Bensaid M. Danset D. Jullien
doi : 10.1111/jdv.16779
Volume34, Issue12December 2020Pages e757-e758
COVID?19 lockdown induced acral dermatosis in children
N. Bodak C. Chiaverini S. Barbarot
doi : 10.1111/jdv.16797
Volume34, Issue12December 2020Pages e758-e760
Prior treatment with immunosuppressants among coronavirus disease 2019 (COVID?19) inpatients at one hospital in Spain
M.A. Pastor?Nieto P. Checa?D?az P. Gonz?lez?Mu?oz A. Mart?n?Fuentes A. Vergara?S?nchez C. S?nchez?Herreros E. Jiménez?Bl?zquez R. Cabana?Navia J. Mart?nez?Mariscal P. Cobo?Rodr?guez I. Checa?Recio M.E. Gatica?Ortega M. Torralba E. De Eusebio?Murillo
doi : 10.1111/jdv.16798
Volume34, Issue12December 2020Pages e760-e762
Dermoscopy features of COVID?19?related chilblains in children and adolescents
L. Navarro D. Andina L. Noguera?Morel A. Hern?ndez?Mart?n I. Colmenero A. Torrelo
doi : 10.1111/jdv.16800
Volume34, Issue12December 2020Pages e762-e764
Concurrent chilblains and retinal vasculitis in a child with COVID?19
L. Quintana?Castanedo M. Feito?Rodr?guez C. Fern?ndez?Alcalde M. Granados?Fern?ndez D. Montero?Vega A. Mayor?Ibarguren R. de Lucas?Laguna
doi : 10.1111/jdv.16801
Volume34, Issue12December 2020Pages e764-e766
STIs and the COVID?19 pandemic: the lockdown does not stop sexual infections
R. Balestri M. Magnano L. Rizzoli S.D. Infusino F. Urbani G. Rech
doi : 10.1111/jdv.16808
Volume34, Issue12December 2020Pages e766-e768
Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID?19
A. Herman M. Matthews M. Mairlot L. Nobile L. Fameree L.?M. Jacquet M. Baeck
doi : 10.1111/jdv.16838
Volume34, Issue12December 2020Pages e768-e700
Management of biological therapies for chronic plaque psoriasis during COVID?19 emergency in Italy
M. Talamonti M. Galluzzo A. Chiricozzi P. Quaglino G. Fabbrocini P. Gisondi A.V. Marzano C. Potenza A. Conti A. Parodi A. Belloni Fortina F. Bardazzi G. Argenziano F. Rongioletti L. Stingeni G. Micali F. Loconsole M. Venturini M.R. Bongiorno C. Feliciani P. Rubegni P. Amerio M.C. Fargnoli P. Pigatto P. Savoia S.P. Nistic? S. Giustini A. Carugno S.P. Cannav? G. Rech F. Prignano A. Offidani M. Lombardo I. Zalaudek L. Bianchi K. Peris PSO?BIO?COVID study group
doi : 10.1111/jdv.16841
Volume34, Issue12December 2020Pages e770-e772
A survey on teledermatology use and doctors’ perception in times of COVID?19
E. Moscarella P. Pasquali E. Cinotti L. Tognetti G. Argenziano P. Rubegni
doi : 10.1111/jdv.16843
Volume34, Issue12December 2020Pages e772-e773
Concerns related to the coronavirus disease 2019 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey
N.D. Loft A.?S. Halling L. Iversen C. Vestergaard M. Deleuran M.K. Rasmussen C. Zachariae J.P. Thyssen L. Skov
doi : 10.1111/jdv.16863
Volume34, Issue12December 2020Pages e773-e776
Severe COVID?19 outcomes in patients with psoriasis
X.T. Lima M.A. Cueva E.M. Lopes M.B. Alora
doi : 10.1111/jdv.16867
Volume34, Issue12December 2020Pages e776-e778
Delayed melanoma diagnosis in the COVID?19 era: increased breslow thickness in primary melanomas seen after the COVID?19 lockdown
F. Ricci L. Fania A. Paradisi G. Di Lella S. Pallotta L. Sobrino A. Panebianco G. Annessi D. Abeni
doi : 10.1111/jdv.16874
Volume34, Issue12December 2020Pages e778-e779
COVID?19?related cutaneous manifestations associated with multiple drug sensitization as shown by lymphocyte transformation test
J. Hayakawa H. Takakura Y. Mizukawa T. Shiohara
doi : 10.1111/jdv.16878
Volume34, Issue12December 2020Pages e779-e781
Scabies outbreak during home confinement due to the SARS?CoV?2 pandemic
I. Mart?nez?Pall?s B. Aldea?Manrique M. Ram?rez?Lluch J. Manuel Vinuesa?Hernando M. Ara?Mart?n
doi : 10.1111/jdv.16879
Volume34, Issue12December 2020Pages e781-e783
Acral skin eruption observed during SARS?CoV?2 pandemic: possible keratolysis exfoliativa with red palms and soles
I. Neri A. Patrizi L. Gabrielli A. Virdi G. Veronesi I. Corsini T. Lazzarotto M. Lanari C. Misciali A. Guglielmo
doi : 10.1111/jdv.16881
Volume34, Issue12December 2020Pages e783-e785
A study on DNA hydroxymethylation in Kaposi sarcoma and cutaneous angiosarcoma
T. Gambichler M. Wrobel S. Koim J.C. Becker H.U. K?fferlein T. Brüning K. Lang
doi : 10.1111/jdv.16444
Volume34, Issue12December 2020Pages e785-e787
Morphology of congenital nevi in dermoscopy and reflectance confocal microscopy according to age: a pilot study
G. Odorici S. Longhitano S. Kaleci J. Chester S. Ciardo G. Pellacani F. Farnetani
doi : 10.1111/jdv.16448
Volume34, Issue12December 2020Pages e787-e789
Profile of smoking dependency in hidradenitis suppurativa patients and smoking cessation outcomes
F. Deilhes R.M. Rouquet Y. Gall C. Aquilina C. Paul M.P. Konstantinou
doi : 10.1111/jdv.16494
Volume34, Issue12December 2020Pages e790-e791
Complete remission of sclerodermatous cutaneous graft?versus?host disease after low?dose interleukine?2 treatment
M. Weiss A. de Masson M. Robin R. Peffault de Latour M. Bagot G. Socié J.?D. Bouaziz
doi : 10.1111/jdv.16524
Volume34, Issue12December 2020Pages e791-e793
Seasonal variation in chronic skin diseases: real?world evidence from a nationwide population?based study in Korea
H.J. Ju J.?w. Kwon Y.C. Lee J.M. Bae
doi : 10.1111/jdv.16612
Volume34, Issue12December 2020Pages e793-e795
Treatment of male and female pattern hair loss with sublingual minoxidil: a retrospective case?series of 64 patients
R. Sinclair L. Trindade de Carvalho F. Ferial Ismail N. Meah
doi : 10.1111/jdv.16616
Volume34, Issue12December 2020Pages e795-e796
Widespread telangiectasia with a possible exogenous explanation
T. Lejding C. Svedman M. Bruze
doi : 10.1111/jdv.16626
Volume34, Issue12December 2020Pages e796-e797
CDKN2A testing threshold in a high?risk Australian melanoma cohort: number of primaries, family history and young age of onset impact risk
E.K. McMeniman E. Peach K.J. Lee T. Yanes K. Jagirdar M.S. Stark H.P. Soyer D.L. Duffy A.M. McInerney?Leo R.A. Sturm
doi : 10.1111/jdv.16627
Volume34, Issue12December 2020Pages e797-e798
Novel topical booster enhances follicular sulfotransferase activity in patients with androgenetic alopecia: a new strategy to improve minoxidil response
P.M. Ramos J. McCoy C. Wambier J. Shapiro S. Va???Galvan R. Sinclair A. Goren
doi : 10.1111/jdv.16645
Volume34, Issue12December 2020Pages e799-e800
The risk of suicidal behaviour in individuals with psoriasis: A retrospective cohort study in Quebec, Canada
A. Laverde?Saad R. Milan S. Mohand?Saïd J. LeLorier I.V. Litvinov E. Rahme
doi : 10.1111/jdv.16647
Volume34, Issue12December 2020Pages e800-e802
Clearance of head and neck involvement in plaque psoriasis with tildrakizumab treatment in the phase 3 reSURFACE 1 study
M.A. Menter G.J. Murakawa H. Glover A.M. Mendelsohn J. Parno S.J. Rozzo D. Davidson A.K. Gupta
doi : 10.1111/jdv.16648
Volume34, Issue12December 2020Pages e803-e805
Light?based therapies and scar sarcoidosis
M. Walther R. Dummer L. Imhof
doi : 10.1111/jdv.16667
Volume34, Issue12December 2020Pages e805-e807
In vivo imaging of Sarcoptes scabiei infestation using line?field confocal optical coherence tomography
C. Ruini S. Schuh G. Pellacani L. French J. Welzel E. Sattler
doi : 10.1111/jdv.16671
Volume34, Issue12December 2020Pages e808-e809
Topical crisaborole is an efficacious steroid?sparing agent for treating mild?to?moderate seborrhoeic dermatitis
S.M. Pe?a A.S.W. Oak A.M. Smith T.T. Mayo B.E. Elewski
doi : 10.1111/jdv.16673
Volume34, Issue12December 2020Pages e809-e812
Likelihood of finding melanoma when removing a melanocytic lesion with peripheral clods
S. Ribero G. Argenziano A. Di Stefani M. Guidante E. Moscarella K. Peris A. Manganoni V. Ingordo I. Zalaudek R. Senetta A. Gambardella M. Venturini N. Di Meo P. Quaglino P. Broganelli
doi : 10.1111/jdv.16674
Volume34, Issue12December 2020Pages e812-e814
Azathioprine in combination with methotrexate may not be a good therapeutic alternative in severe and recalcitrant forms of alopecia areata
F. Ansari S. Singh
doi : 10.1111/jdv.16675
Volume34, Issue12December 2020Pages e814-e815
The impact of prurigo nodularis on sleep disturbance and related impact: a systematic review
E.C. Gwillim S.R. Janmohamed M. Yousaf K.R. Patel J.I. Silverberg
doi : 10.1111/jdv.16696
Volume34, Issue12December 2020Pages e815-e817
Serum thymus and activation?regulated chemokine levels before and after treatment for pruritic scabies
Y. Arakawa R. Tamagawa?Mineoka K. Masuda N. Katoh
doi : 10.1111/jdv.16698
Volume34, Issue12December 2020Pages e817-e818
An extraordinary outbreak of scabies in Turkey
M.G. ?zden K. Ertürk S.P. Kartal S. Yayli F. G?ktay C.A. Do?ramac? D. Bayramgürler Z. ?zgen S. ?nder N. Kaçar M. Meliko?lu F. Tamer N. ?entürk E. Alpsoy
doi : 10.1111/jdv.16699
Volume34, Issue12December 2020Pages e818-e820
A network analysis of the EADV 2019 conference
R. Kaczmarczyk F. Bauerdorf L. Tizek T. Biedermann A. Zink
doi : 10.1111/jdv.16700
Volume34, Issue12December 2020Pages e820-e822
Dermatology Life Quality Index use in skin disease guidelines and registries worldwide
R.K. Singh A.Y. Finlay
doi : 10.1111/jdv.16701
Volume34, Issue12December 2020Pages e822-e824
Dynamics of epidermal carotenoid levels in vivo of healthy subjects in Antarctica
N. Tsankov D. Mateev I. Bogdanov R. Darlenski
doi : 10.1111/jdv.16702
Volume34, Issue12December 2020Pages e824-e825
The Fc? receptor I pathway is crucial but not exclusive for basophil activation in patients with autoimmune forms of chronic spontaneous urticaria
L. J?rg N. Mueller?Wirth T. Pecaric?Petkovic C. Diaz W. Pichler O. Hausmann
doi : 10.1111/jdv.16703
Volume34, Issue12December 2020Pages e825-e827
What counts? The relationship between patient estimated numbers of painful hidradenitis suppurativa lesions over 4 weeks compared with clinician's lesion count at the time of examination
R. Kj?rsgaard Andersen D.M.L. Saunte G.B.E. Jemec
doi : 10.1111/jdv.16704
Volume34, Issue12December 2020Pages e827-e830
Dermatologic surgery in centenarians
G. Gualdi P. Monari S. Soglia P. Taddeucci M. Fimiani F. Savoia D. Melandri S. Caccavale G. Argenziano P. Calzavara?Pinton P. Amerio
doi : 10.1111/jdv.16708
Volume34, Issue12December 2020Pages e830-e832
Protothecosis: the alterations in the human foot microbiome – a case study
K. Adamczyk D. Wcis?o?Dziadecka A. Garncarczyk A. Lubczy?ska E. Chodurek
doi : 10.1111/jdv.16712
Volume34, Issue12December 2020Pages e832-e834
RANK?RANKL signalling pathway contributes to disease progression in cutaneous angiosarcoma: a case report with an immunohistochemical review and in vitro experiments
T. Maeda S. Kitamura T. Yanagi
doi : 10.1111/jdv.16714
Volume34, Issue12December 2020Pages e834-e837
Real?life effectiveness and short?term (16?week) tolerance of guselkumab for psoriasis: a Belgian retrospective multicentre study
F. Benhadou P.D. Ghislain F. Guiot F. Willaert V. Del Marmol J. Lambert R. Soenen H. Fierens M. de la Brassinne
doi : 10.1111/jdv.16715
Volume34, Issue12December 2020Pages e837-e839
European Task Force on Atopic Dermatitis (ETFAD): treatment targets and treatable traits in atopic dermatitis
J.P. Thyssen C. Vestergaard M. Deleuran M.S. de Bruin?Weller T. Bieber A. Taieb J. Seneschal M.J. Cork C. Paul C. Flohr S. Weidinger M. Trzeciak T. Werfel A. Heratizadeh S. Barbarot U. Darsow D. Simon A. Torrelo P.V. Chernyshov J.?F. Stalder C. Gelmetti Z. Szalai ?. Svensson L.B. von Kobyletzki L. De Raeve R. F?lster?Holst S. Cristen?Zaech D. Hijnen U. Gieler J. Ring A. Wollenberg
doi : 10.1111/jdv.16716
Volume34, Issue12December 2020Pages e839-e842
Immunohistochemistry analysis of itch and pain mediators in nonmelanoma skin cancer
E. Fowler J. Rosen S.M. Shah L. Strowd J.C. Tang L.A. Nattkemper G. Yosipovitch
doi : 10.1111/jdv.16717
Volume34, Issue12December 2020Pages e842-e843
Efficacy of cold atmospheric plasma vs. diclofenac 3% gel in patients with actinic keratoses: a prospective, randomized and rater?blinded study (ACTICAP)
F. Koch K.A. Salva M. Wirtz E. Hadaschik R. Varaljai D. Schadendorf A. Roesch
doi : 10.1111/jdv.16735
Volume34, Issue12December 2020Pages e844-e846
Risk factors for corticophobia in atopic dermatitis
H. Dufresne P. Bataille N. Bellon S. Compain E. Deladrière L. Bekel E. Sbidian C. Bodemer S. Hadj?Rabia
doi : 10.1111/jdv.16739
Volume34, Issue12December 2020Pages e846-e849
Frequency and characteristics of pruritus in patients with monoclonal gammopathy: a case–control study
C. Devergne H. Kerspern F. Poizeau J.R. Eveillard J.L. Carré L. Misery C. Le Gall?Ianotto E. Brenaut
doi : 10.1111/jdv.16743
Volume34, Issue12December 2020Pages e849-e852
Further evidence for the immediate knowledge improvement through EADV Schools on hidradenitis suppurativa/acne inversa
C.C. Zouboulis V. del Marmol G.B.E. Jemec A.C. Katoulis E. Prens E.J. Giamarellos?Bourboulis
doi : 10.1111/jdv.16744
Volume34, Issue12December 2020Pages e852-e853
